Researchers have developed a new method to target and kill specific bacteria using viruses, an advance that may help overcome the growing threat of antibiotic resistance.
The results of the study, published in the journal Cell, showed that bacteria-infecting viruses called bacteriophages, or simply phages, could kill different strains of the bacterium E. coli by making mutations in a viral protein that bound to host cells.
The researchers, including those from Massachusetts Institute of Technology (MIT) in the US, collaborating with the US Army, showed that the phages they tweaked in the lab were less likely to provoke resistance in bacteria.
According to the researchers, antibiotic resistance is one of the most pressing public health concerns in the world.
For instance, a recent study, published in the journal Science, revealed that the rates of antibiotic resistance in bacteria present in animals raised for meat nearly doubled since 2000.
"Finding a cure for antibiotic-resistant bacteria is particularly important for soldiers who are deployed to parts of the world where they may encounter unknown pathogens or even antibiotic-resistant bacteria," said James Burgess, programme manager in the US Army.
Burgess added that wounded soldiers are even more susceptible to infections, and may come home carrying the drug-resistant bugs.
To tackle this looming crisis, the researchers created several engineered phages that could kill E. coli grown in the lab.
The team created phages with about 10 million different configurations to the part of the virus that attached to bacteria, called the tail fibres.
The researchers tested these variants against several strains of E. coli that had evolved to be resistant to the natural bacteriophage.
One way in which the E. coli became resistant to bacteriophages was by mutating certain receptors on its surface, the study noted.
But, the MIT team found that some of their lab grown phages could kill even strains of E. coli missing these receptors.
One of the newly created phages, the researchers said, could eliminate two E. coli strains that were resistant to naturally occurring phages.
"Phages represent a very different way of killing bacteria than antibiotics, which is complementary to antibiotics, rather than trying to replace them," said Timothy Lu, senior author of the study from MIT.
The researchers said that the Food and Drug Administration (FDA) in the US has approved treatments for killing harmful bacteria in food using bacteriophages.
However, they added that the method is not widely used to treat infections since finding naturally occurring phages that can target the right kind of bacteria is a "difficult and time-consuming process."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
